WIN 55,212-2 is a widely used research tool for exploring the endocannabinoid system. Unlike the primary psychoactive component of marijuana, THC, which is a partial agonist, WIN 55,212-2 acts as a at both CB1 and CB2 cannabinoid receptors.
It binds strongly to CB1 receptors found primarily in the brain, influencing neurotransmitter release and impacting memory, pain sensation, and motor control. 55212.rar
It also has a high affinity for CB2 receptors, which are largely located in the immune system and are targeted for research into anti-inflammatory and neuropathic pain treatments. WIN 55,212-2 is a widely used research tool
Studies often use WIN 55,212-2 as a benchmark to compare the effectiveness of other ligands or to test how allosteric modulators can alter receptor signaling. Common Uses in Research Research involving WIN 55,212-2 typically focuses on: It also has a high affinity for CB2